Epstein-Barr Virus Antibodies to Differentiate Multiple Sclerosis From Other Neuroinflammatory Diseases

20260 citationsJournal Articlegreen Open Access

Authors

Hannes Vietzen · Medical University of Vienna

Laura M. Kühner · Medical University of Vienna

S. Berger · Medical University of Vienna

Raphael Reinecke · Medical University of Vienna

Kevin Rostásy · Witten/Herdecke University

Henrieke Saucke · Witten/Herdecke University

Franziska Kauth

Abstract

Results of this case-control study reveal that persistent high-level EBNA-1 peptide antibody titers may serve as a reliable biomarker for differentiating MS from MOGAD, and NMOSD.

Topics & Keywords

Multiple Sclerosis Research Studies Autoimmune Neurological Disorders and Treatments Peripheral Neuropathies and Disorders

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: JAMA Neurology

DOI: 10.1001/jamaneurol.2026.0240

Field-Weighted Citation Impact: 0.00